Newsfeeds - Spark Newswire

2 minute read

FDA
News

Reviva Pharmaceuticals Holdings, Inc. Receives FDA May Proceed Letter For Pivotal Phase 3 Clinical Trial And Long-Term Safety Trial Evaluating Brilaroxazine For The Treatment Of Schizophrenia

Today, 8:33 PM

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular,

RVPH

1 minute read

Reviva Pharmaceuticals Q3 EPS $(0.12)

By Benzinga Newsdesk

Today, 8:33 PM

Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.12) per share.

RVPH

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 8:33 PM

CALT

6 minute read

Uncategorized

RVPH: Second Quarter Update

By Zacks Small Cap Research

Today, 8:33 PM

By John Vandermosten, CFA NASDAQ:RVPH READ THE FULL RVPH RESEARCH REPORT

RVPH

6 minute read

60 Biggest Movers From Yesterday

By Lisa Levin

Today, 8:33 PM

Gainers

AGFY

2 minute read

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 8:33 PM

BPTH

4 minute read

38 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 8:33 PM

Gainers Triple-S Management Corporation (NYSE: GTS) shares jumped 45.3% to $35.15. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield of Florida Inc, will acquire Triple-S Management for an equity value of approximately $900 million.

ATER

1 minute read

Reviva Pharmaceuticals Q2 EPS $(0.23) Up From $(0.58) YoY

By Benzinga Newsdesk

Today, 8:33 PM

Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.23) per share. This is a 60.34 percent increase over losses of $(0.58) per share from the same period last year.

RVPH